Skip to content
2000
Volume 10, Issue 1
  • ISSN: 2212-697X
  • E-ISSN: 2212-6988

Abstract

Background

Lymphatic transport is indispensable for maintaining tissue homeostasis and orchestrating immune surveillance. However, its association with solid tumor development and dissemination poses a paradox. While initially perceived as a passive conduit for metastasis, recent research highlights the active involvement of lymphatic vessels in tumor progression, inflammation, and immune surveillance.

Objective

This study aims to elucidate the active mechanisms underlying lymphatic transport's contribution to peripheral tissue immunity and its dual role in tumor-associated immune responses. Additionally, it explores emerging areas of interest in targeted cancer immunotherapy.

Methods

A comprehensive literature review was conducted to gather insights into the role of lymphatic transport in both physiological and pathological contexts, with a focus on cancer progression and immune modulation. Relevant studies and reviews were analyzed to provide current understanding and identify future directions in cancer immunotherapy.

Results

Lymphatic vessels actively shape their transport function to influence peripheral tissue immunity, facilitating immune cell trafficking and antigen drainage. However, tumor-associated lymphatic remodeling disrupts this balance, promoting tumor dissemination and fostering a pro-tumorigenic microenvironment. Emerging research implicates lymphatic vessels in the formation of tertiary lymphoid structures, immune surveillance in the central nervous system, and interactions with the microbiome, obesity, and aging, highlighting their multifaceted role in cancer immunity.

Conclusion

Insights gained in lymphatic biology offer promising avenues for enhancing cancer immunotherapy by targeting lymphatic vessels and their transport function. A comprehensive understanding of lymphatic involvement in cancer pathogenesis supports its integration into therapeutic strategies to optimize immune surveillance and improve patient outcomes.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccand/10.2174/012212697X339680241118072504
2024-01-01
2025-10-08

  • From This Site

    /content/journals/ccand/10.2174/012212697X339680241118072504
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LiC.Y. BrownS. MehraraB.J. KataruR.P. Lymphatics in tumor progression and immunomodulation.Int. J. Mol. Sci.2022234212710.3390/ijms23042127 35216243
     [Google Scholar]
  2. ZhouH. LeiP.J. PaderaT.P. Progression of metastasis through lymphatic system.Cells202110362710.3390/cells10030627
     [Google Scholar]
  3. RezzolaS. SigmundE.C. HalinC. RoncaR. The lymphatic vasculature: An active and dynamic player in cancer progression.Med. Res. Rev.202242157661410.1002/med.21855 34486138
     [Google Scholar]
  4. SassoM.S. MitrousisN. WangY. Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.Sci. Adv.2021713eabe436210.1126/sciadv.abe4362 33762337
     [Google Scholar]
  5. DengH. ZhangJ. WuF. Current status of lymphangiogenesis: Molecular mechanism, immune tolerance, and application prospect.Cancers (Basel)2023154116910.3390/cancers15041169 36831512
     [Google Scholar]
  6. FarnsworthRH KarnezisT MaciburkoSJ MuellerSN StackerSA The interplay between lymphatic vessels and chemokines.Front Immunol20191051810.3389/fimmu.2019.0051831105685
     [Google Scholar]
  7. LiaoS. PaderaT.P. Lymphatic function and immune regulation in health and disease.Lymphat. Res. Biol.201311313614310.1089/lrb.2013.0012 24024577
     [Google Scholar]
  8. ArasaJ. Collado-DiazV. HalinC. Structure and immune function of afferent lymphatics and their mechanistic contribution to dendritic cell and T cell trafficking.Cells2021105126910.3390/cells10051269 34065513
     [Google Scholar]
  9. LeiP.J. FraserC. JonesD. UbellackerJ.M. PaderaT.P. Lymphatic system regulation of anti-cancer immunity and metastasis.Front. Immunol.202415144929110.3389/fimmu.2024.1449291 39211044
     [Google Scholar]
  10. SteeleM.M. LundA.W. Afferent lymphatic transport and peripheral tissue immunity.J. Immunol.2021206226427210.4049/jimmunol.2001060 33397740
     [Google Scholar]
  11. KhanS.U. KhanM.U. Azhar Ud DinM. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.Front. Immunol.202314116648710.3389/fimmu.2023.1166487 37138860
     [Google Scholar]
  12. AngeliV. LimH.Y. Biomechanical control of lymphatic vessel physiology and functions.Cell. Mol. Immunol.20232091051106210.1038/s41423‑023‑01042‑9 37264249
     [Google Scholar]
  13. GonzalezH. HagerlingC. WerbZ. Roles of the immune system in cancer: From tumor initiation to metastatic progression.Genes Dev.20183219-201267128410.1101/gad.314617.118 30275043
     [Google Scholar]
  14. Hiam-GalvezK.J. AllenB.M. SpitzerM.H. Systemic immunity in cancer.Nat. Rev. Cancer202121634535910.1038/s41568‑021‑00347‑z 33837297
     [Google Scholar]
  15. DieterichL.C. TacconiC. DucoliL. DetmarM. Lymphatic vessels in cancer.Physiol. Rev.202210241837187910.1152/physrev.00039.2021 35771983
     [Google Scholar]
  16. FujimotoN. DieterichL.C. Mechanisms and clinical significance of tumor lymphatic invasion.Cells20211010258510.3390/cells10102585 34685565
     [Google Scholar]
  17. EscalanteC.P. ZalpourA. Vascular endothelial growth factor inhibitor-induced hypertension: Basics for primary care providers.Cardiol. Res. Pract.201120111810.4061/2011/816897 21629798
     [Google Scholar]
  18. PaderaT.P. MeijerE.F.J. MunnL.L. The lymphatic system in disease processes and cancer progression.Annu. Rev. Biomed. Eng.201618112515810.1146/annurev‑bioeng‑112315‑031200 26863922
     [Google Scholar]
  19. Collado-DiazV. Medina-SanchezJ.D. GkountidiA.O. HalinC. Imaging leukocyte migration through afferent lymphatics.Immunol. Rev.20223061435710.1111/imr.13030 34708414
     [Google Scholar]
  20. HuZ. ZhaoX. WuZ. Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets.Signal Transduct. Target. Ther.202491910.1038/s41392‑023‑01723‑x 38172098
     [Google Scholar]
  21. SridharanB. LimH.G. Advances in photoacoustic imaging aided by nano contrast agents: Special focus on role of lymphatic system imaging for cancer theranostics.J. Nanobiotechnology202321143710.1186/s12951‑023‑02192‑8 37986071
     [Google Scholar]
  22. YinJ. WangH. ZhuG. ChenN. KhanM.I. ZhaoY. Prognostic value of whole-body dynamic 18F-FDG PET/CT Patlak in diffuse large B-cell lymphoma.Heliyon202399e1974910.1016/j.heliyon.2023.e19749 37809527
     [Google Scholar]
/content/journals/ccand/10.2174/012212697X339680241118072504
Loading
A Quest for the Dual Role of Lymphatic Transport in Cancer: From Immune Surveillance to Tumour Dissemination
Clinical Cancer Drugs 10, E2212697X339680 (2024); https://doi.org/10.2174/012212697X339680241118072504
/content/journals/ccand/10.2174/012212697X339680241118072504
/content/journals/ccand/10.2174/012212697X339680241118072504
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): cancer immunotherapy; immune surveillance; inflammatory networks; Lymphatic transport; tissue homeostasis; tumor progression

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test